TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA
Clinical trials for TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill may cut blood transfusions for kids with thalassemia
Disease control Recruiting nowThis study tests a drug called mitapivat in children aged 1 to 17 with alpha- or beta-thalassemia who need regular blood transfusions. The goal is to see if mitapivat can reduce the number of transfusions needed compared to a placebo. The study involves 54 participants and lasts …
Matched conditions: TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New stem cell transplant trial aims to treat sickle cell disease and other blood disorders
Disease control Recruiting nowThis phase 2 trial tests a stem cell transplant from a donor for people with high-risk sickle cell disease, thalassemia, and other red blood cell disorders. Participants receive drugs and low-dose radiation before the transplant to help the new cells take hold. The study will tra…
Matched conditions: TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC